ReviewDelays in diagnosis of paediatric cancers: a systematic review and comparison with expert testimony in lawsuits
Introduction
In high-income countries, about one child per 440 will develop cancer beforethe age of 15 years.1, 2 Cancer accounts for 19% of deaths in children older than 1 year in Europe.3 Delayed diagnosis of paediatric tumours has been reported regularly for more than 50 years4 and leads to feelings of remorse or guilt for parents and physicians, loss of confidence, and sometimes conflicts.5, 6 In some countries, more malpractice claims related to diagnostic errors are associated with cancer than with any other disease in children.7
The only review8 of delayed diagnosis in paediatric cancer so far (published in 2007) stated that “the impact of diagnostic delays on the prognosis of children with cancer is still unknown” and that “more studies are needed to investigate this potential impact”. However, this review did not follow specific methods, pooled studies from developing and developed countries, and did not include all papers published before 2007 (the authors selected only 21 of the 64 eligible studies published in English from developed countries). Since 2007, more research has been published, including that about the consequences of delayed diagnosis.
We aimed to do a systematic review of available information about the distribution, determinants, and consequences of time to diagnosis of paediatric cancers and thus to identify tumours for which long time to diagnosis is not associated with adverse outcome (information that could reduce guilt in parents and physicians about the consequences of these delays and improve the quality of the reports of court-appointed experts in malpractice claims) or more research is needed. Our secondary objective was to compare available information about the consequences of long time to diagnosis with the conclusions of court-appointed experts in malpractice claims.
Section snippets
Search strategy and selection criteria
We systematically reviewed studies until Dec 31, 2011 (inclusive) about the distribution, determinants, and consequences of time to diagnosis of paediatric cancers—specifically, leukaemias, lymphomas, brain tumours, neuroblastomas, kidney tumours, bone tumours, soft-tissue sarcomas, germ-cell tumours, and retinoblastomas. We excluded rare malignancies—ie, those accounting for less than 1·5% of the total incidence of childhood cancers (eg, hepatic tumours, malignant epithelial neoplasms, and
Data extraction and analysis
MM and J-FB independently extracted data for the distribution, determinants, and consequences of time to diagnosis (MC resolved discrepancies). Time to diagnosis (which we converted to weeks for our analysis) was defined in all studies as the interval between the first symptom attributable to the disease and final diagnosis. In some studies, it was separated into patient-associated delay (ie, the interval between onset of symptoms and first medical consultation) and doctor-associated delay (ie,
Clinical data
We identified 6412 studies; we assessed the full texts of 378 for eligibility and included 98 in our final analysis (appendix). 56% of the studies were published during or after 2000. The total sample was 22 619 patients.
Four of the ten studies in which investigators looked at time to diagnosis during the studies showed a significant decrease (brain tumours,33, 34 retinoblastoma,35 and all tumours pooled27) in the overall time to diagnosis or doctor's delay. Conversely, no significant
Discussion
We conclude, based on our review, that no adverse association and sometimes even a paradoxical positive relation exists between a long time to diagnosis and outcome for most types of CNS tumours (the extent of initial tumour invasion and survival) and osteosarcoma and Ewing's sarcoma (initial invasion and possibly survival). The relation between time to diagnosis and poor outcome for retinoblastoma (initial invasion, survival, and blindness) is well established. Because data are few and from
Conclusion
The general belief that a long delay before diagnosis of paediatric cancers leads to worse prognosis is often untrue. For most paediatric cancers, time to diagnosis probably depends most on the tumour's biology.8, 16, 20, 26, 33, 42, 108 The apparently contradictory relation between a long time to diagnosis and better outcomes that is noted in some studies does not mean that diagnosis should be delayed on purpose. Early referral to specialists could help with anxiety and distress in patients
References (115)
Epidemiology of childhood cancer
Cancer Treat Rev
(2010)- et al.
The epidemiology of childhood mortality in the European Union
Curr Paediatr
(2005) - et al.
Parents' accounts of obtaining a diagnosis of childhood cancer
Lancet
(2001) - et al.
The role of the doctor and the medical system in the diagnostic delay in pediatric malignancies
Cancer Epidemiol
(2011) - et al.
Brain tumors in childhood and adolescence
Pediatr Neurol
(1999) - et al.
Symptom interval in young people with bone cancer
Eur J Cancer
(2004) - et al.
Interval between symptom onset and diagnosis of pediatric solid tumors
J Pediatr
(1991) - et al.
A long duration of the prediagnostic symptomatic interval is not associated with an unfavourable prognosis in childhood medulloblastoma
Eur J Cancer
(2012) - et al.
Clinical and neuroradiologic findings in infants with intracranial ependymomas. Pediatric Oncology Group
Pediatr Neurol
(1998) - et al.
Presentation of childhood CNS tumours: a systematic review and meta-analysis
Lancet Oncol
(2007)
Incidence of childhood cancer in France: National Children Cancer Registries, 2000-2004
Eur J Cancer Prev
Neurosurgery of infancy and childhood
Parents as advocates: stories of surplus suffering when a child is diagnosed and treated for cancer
Soc Work Health Care
Epidemiology and aetiology of paediatric malpractice claims in France
Arch Dis Child
Diagnosis delays in childhood cancer: a review
Cancer
Systematic reviews: CRD's guidance for undertaking reviews in health care
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
PLoS Med
Usefulness of systematic review search strategies in finding child health systematic reviews in Medline
Arch Pediatr Adolesc Med
World economic and financial surveys: world economic outlook
Delayed diagnosis and tumor stage in Ewing's sarcoma
Oncol Rep
Ewing's sarcoma of bone: relation between clinical characteristics and staging
Oncol Rep
Delay in diagnosis of children with cancer: a retrospective study of 315 children
Pediatr Hematol Oncol
Impact of age and diagnosis on waiting times between important healthcare events among children 0 to 19 years cared for in pediatric units: the Canadian Childhood Cancer Surveillance and Control Program
J Pediatr Hematol Oncol
Waiting times for cancer care in Canadian children: impact of distance, clinical, and demographic factors
Pediatr Blood Cancer
Is there a correlation between duration of presenting symptoms and stage of medulloblastoma at the time of diagnosis?
Cancer
Duration of symptoms prior to diagnosis is related inversely to presenting disease stage in children with medulloblastoma
Cancer
Malignant tumours of the cerebral hemisphere in children. A series of 64 cases
Arch Fr Pediatr
Malignant hemispheric tumors in childhood
Childs Nerv Syst
Ependymomas: a clinical and pathologic study. Part I. Biologic features
Clin Neuropathol
Ependymomas: a clinical and pathologic study. Part II. Survival features
Clin Neuropathol
Interval between onset of symptoms and diagnosis of medulloblastoma in children: distribution and determinants in a population-based study
Eur J Pediatr
Long time to diagnosis of medulloblastoma in children is not associated with decreased survival or with worse neurological outcome
PLoS One
Delays in diagnosis and treatment among children and adolescents with cancer in Canada
Pediatr Blood Cancer
Determinants of delays in treatment initiation in children and adolescents diagnosed with leukemia or lymphoma in Canada
Int J Cancer
Diagnostic delay in pediatric solid tumors: a population based study on determinants and impact on outcomes
Pediatr Blood Cancer
Delays in diagnosis of pediatric solid tumors in Singapore
J Pediatr Hematol Oncol
QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies
Ann Intern Med
International classification of childhood cancer, third edition
Cancer
Does diagnostic delay result in decreased survival in paediatric brain tumours?
Eur J Pediatr
Delay in the diagnosis of paediatric brain tumours
Eur J Pediatr
Shorter time to diagnosis and improved stage at presentation in Swiss patients with retinoblastoma treated from 1963 to 2004
Pediatrics
Brain tumors in children: initial symptoms and their influence on the time span between symptom onset and diagnosis
J Child Neurol
The symptom interval in children and adolescents with soft tissue sarcomas
Cancer
Variability in the presentation of synovial sarcoma in children: a plea for greater awareness
J Bone Joint Surg Br
Determinants of symptom interval in childhood cancer
Arch Dis Child
The presenting features of brain tumours: a review of 200 cases
Arch Dis Child
Delay in diagnosis of retinoblastoma: risk factors and treatment outcome
Br J Ophthalmol
Delay in the diagnosis of pediatric brain tumors
Am J Dis Child
Latency between symptom onset and diagnosis of pediatric brain tumors: an eastern Canadian geographic study
Neurosurgery
Cerebellar astrocytomas. Clinical characteristics and prognostic indices
J Neurooncol
Cited by (0)
- †
These authors contributed equally